Kenvue & United States — Food and Drug Administration

Kenvue: Kenvue, the manufacturer of Tylenol, strongly disagreed with the suggestion that acetaminophen causes autism, defending the drug's safety and warning of risks from untreated fever or pain.

United States — Food and Drug Administration: The United States — Food and Drug Administration was directed by Donald Trump to issue new guidance on acetaminophen and approved leucovorin for autism treatment, facing scrutiny for its scientific basis.

Kenvue: Kenvue, the maker of Tylenol, disputed any link between the drug and autism. Its shares fell 7.5% in trading, reducing its market value by about $2.6 billion due to Donald Trump's statements.

United States — Food and Drug Administration: The United States — Food and Drug Administration is expected to notify doctors about a potential association between acetaminophen and autism, a recommendation that lacks immediate medical evidence and is controversial.

Kenvue: Kenvue Brands, the parent company of Johnson & Johnson — Neutrogena, issued the recall for the contaminated wipes, facing potential financial and reputational consequences.

United States — Food and Drug Administration: The United States — Food and Drug Administration assigned a Class II risk level to the recall, overseeing the process and informing the public about the potential health risks.

Kenvue: Kenvue, the manufacturer of Tylenol, refuted the claims made by Robert F. Kennedy Jr. and Donald Trump, stating that studies have found no causal link between acetaminophen use during pregnancy and fetal developmental issues.

United States — Food and Drug Administration: The United States — Food and Drug Administration advises against the use of ibuprofen after 20 weeks of pregnancy, making acetaminophen a common alternative for pregnant women, which is relevant to the discussion around Tylenol.

Kenvue: Kenvue is being acquired by Kimberly-Clark for $48.7 billion, providing a significant premium to its shareholders. Kenvue's stock surged after the announcement, despite facing scrutiny over Tylenol and activist investor pressure.

United States — Food and Drug Administration: The United States — Food and Drug Administration advised doctors to consider minimizing acetaminophen's use in pregnancy, amid inconclusive evidence about a link to autism.

Kenvue: Kenvue, the manufacturer of Tylenol (paracetamol), faced a lawsuit regarding alleged links between its product and autism, which was dismissed. The new study supports the safety of its product.